Skip to main content
Erschienen in: Archives of Dermatological Research 2/2012

01.03.2012 | Original Paper

Psoriasis increased the risk of diabetes: a meta-analysis

verfasst von: Juan Cheng, Dayu Kuai, Li Zhang, Xueqin Yang, Bing Qiu

Erschienen in: Archives of Dermatological Research | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

To evaluate the association between psoriasis and risk of diabetes, pertinent studies were identified by searching electronic databases and by reviewing the reference lists of retrieved articles. We included observational studies that examined the association between psoriasis and risk of diabetes. Two reviewers independently assessed eligibility and used a standardized form to collect data from published studies. The study quality was assessed by the Newcastle–Ottawa Scale. A total of 22 eligible studies that included 3,307,516 participants fulfilled the inclusion criteria. Compared to individuals without psoriasis, subjects with psoriasis had a 1.42-fold increased risk of diabetes (95% CI, 1.40–1.45). Findings from this meta-analysis suggest that individuals with psoriasis may have a modestly increased risk of diabetes.
Literatur
1.
Zurück zum Zitat Alexander E, Pinto J, Pal GS, Kamath N, Kuruvilla M (2001) Disease concomitance in psoriasis: a clinical study of 61 cases. Indian J Dermatol Venereol Leprol 67:66–68PubMed Alexander E, Pinto J, Pal GS, Kamath N, Kuruvilla M (2001) Disease concomitance in psoriasis: a clinical study of 61 cases. Indian J Dermatol Venereol Leprol 67:66–68PubMed
2.
Zurück zum Zitat Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M (2010) Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol 37:146–155PubMedCrossRef Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M (2010) Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol 37:146–155PubMedCrossRef
3.
Zurück zum Zitat Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schäfer I (2010) Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 162:633–636PubMedCrossRef Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schäfer I (2010) Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 162:633–636PubMedCrossRef
4.
Zurück zum Zitat Boehncke S, Fichtlscherer S, Salgo R, Garbaraviciene J, Beschmann H, Diehl S, Hardt K, Thaçi D, Boehncke WH (2011) Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial. Arch Dermatol Res 303:381–388PubMedCrossRef Boehncke S, Fichtlscherer S, Salgo R, Garbaraviciene J, Beschmann H, Diehl S, Hardt K, Thaçi D, Boehncke WH (2011) Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial. Arch Dermatol Res 303:381–388PubMedCrossRef
5.
Zurück zum Zitat Boehncke WH, Boehncke S, Tobin AM, Kirby B (2011) The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 20:303–307PubMedCrossRef Boehncke WH, Boehncke S, Tobin AM, Kirby B (2011) The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 20:303–307PubMedCrossRef
6.
Zurück zum Zitat Boehncke WH, Boehncke S, Schon MP (2010) Managing comorbid disease in patients with psoriasis. BMJ 340:b5666PubMedCrossRef Boehncke WH, Boehncke S, Schon MP (2010) Managing comorbid disease in patients with psoriasis. BMJ 340:b5666PubMedCrossRef
7.
Zurück zum Zitat Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C (1999) Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 28:1–9PubMedCrossRef Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C (1999) Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 28:1–9PubMedCrossRef
8.
Zurück zum Zitat Brauchli YB, Jick SS, Meier CR (2008) Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol 159:1331–1337PubMedCrossRef Brauchli YB, Jick SS, Meier CR (2008) Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol 159:1331–1337PubMedCrossRef
9.
Zurück zum Zitat Chen YJ, Wu CY, Shen JL, Chu SY, Chen CK, Chang YT, Chen CM (2008) Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol 144:1571–1575PubMedCrossRef Chen YJ, Wu CY, Shen JL, Chu SY, Chen CK, Chang YT, Chen CM (2008) Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol 144:1571–1575PubMedCrossRef
10.
Zurück zum Zitat Cohen AD, Dreiher J, Shapiro Y, Vidavsky L, Vardy DA, Davidovici B, Meyerovitch J (2008) Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol Venereol 22:585–589PubMedCrossRef Cohen AD, Dreiher J, Shapiro Y, Vidavsky L, Vardy DA, Davidovici B, Meyerovitch J (2008) Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol Venereol 22:585–589PubMedCrossRef
11.
Zurück zum Zitat Das SK, Elbein SC (2007) The search for type 2 diabetes susceptibility loci: the chromosome 1q story. Curr Diab Rep 7:154–164PubMedCrossRef Das SK, Elbein SC (2007) The search for type 2 diabetes susceptibility loci: the chromosome 1q story. Curr Diab Rep 7:154–164PubMedCrossRef
12.
Zurück zum Zitat Ding EL, Hu FB (2007) Smoking and type 2 diabetes: under recognized risks and disease burden. JAMA 298:2675–2676PubMedCrossRef Ding EL, Hu FB (2007) Smoking and type 2 diabetes: under recognized risks and disease burden. JAMA 298:2675–2676PubMedCrossRef
13.
Zurück zum Zitat Driessen RJ, Boezeman JB, Van de Kerkhof PC, De Jong EM (2009) Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies. J Dermatol Treat 20:42–47CrossRef Driessen RJ, Boezeman JB, Van de Kerkhof PC, De Jong EM (2009) Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies. J Dermatol Treat 20:42–47CrossRef
14.
Zurück zum Zitat Foy CG, Bell RA, Farmer DF, Goff DC Jr, Wagenknecht LE (2005) Smoking and incidence of diabetes among U.S. adults:findings from the Insulin Resistance Atherosclerosis Study. Diabetes Care 28:2501–2507PubMedCrossRef Foy CG, Bell RA, Farmer DF, Goff DC Jr, Wagenknecht LE (2005) Smoking and incidence of diabetes among U.S. adults:findings from the Insulin Resistance Atherosclerosis Study. Diabetes Care 28:2501–2507PubMedCrossRef
15.
Zurück zum Zitat Fuller JH, Stevens LK, Wang SL (2001) Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia 44 (Suppl 2):S54–S64PubMedCrossRef Fuller JH, Stevens LK, Wang SL (2001) Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia 44 (Suppl 2):S54–S64PubMedCrossRef
16.
Zurück zum Zitat Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ (2005) Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 141:1537–1541PubMedCrossRef Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ (2005) Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 141:1537–1541PubMedCrossRef
17.
Zurück zum Zitat Gerdes S, Zahl VA, Knopf H, Weichenthal M, Mrowietz U (2008) Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis. Br J Dermatol 159:1116–1123PubMed Gerdes S, Zahl VA, Knopf H, Weichenthal M, Mrowietz U (2008) Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis. Br J Dermatol 159:1116–1123PubMed
18.
Zurück zum Zitat Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, Giannetti A, Girolomoni G (2007) Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 157:68–73PubMedCrossRef Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, Giannetti A, Girolomoni G (2007) Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 157:68–73PubMedCrossRef
19.
Zurück zum Zitat Hill MJ, Metcalfe D, McTernan PG (2009) Obesity and diabetes: lipids, ‘nowhere to run to’. Clin Sci (Lond) 116:113–123CrossRef Hill MJ, Metcalfe D, McTernan PG (2009) Obesity and diabetes: lipids, ‘nowhere to run to’. Clin Sci (Lond) 116:113–123CrossRef
20.
Zurück zum Zitat Huerta C, Rivero E, Rodríguez LA (2007) Incidence and risk factors for psoriasis in the general population. Arch Dermatol 143:1559–1565PubMedCrossRef Huerta C, Rivero E, Rodríguez LA (2007) Incidence and risk factors for psoriasis in the general population. Arch Dermatol 143:1559–1565PubMedCrossRef
21.
Zurück zum Zitat Kaye JA, Li L, Jick SS (2008) Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 159:895–902PubMedCrossRef Kaye JA, Li L, Jick SS (2008) Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 159:895–902PubMedCrossRef
22.
Zurück zum Zitat Kimball AB, Robinson D Jr, Wu Y, Guzzo C, Yeilding N, Paramore C, Fraeman K, Bala M (2008) Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001–2002. Dermatology 217:27–37PubMedCrossRef Kimball AB, Robinson D Jr, Wu Y, Guzzo C, Yeilding N, Paramore C, Fraeman K, Bala M (2008) Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001–2002. Dermatology 217:27–37PubMedCrossRef
23.
Zurück zum Zitat Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D’Agostino RB (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91:2906–2912PubMedCrossRef Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D’Agostino RB (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91:2906–2912PubMedCrossRef
24.
Zurück zum Zitat Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors 2001. JAMA 289:76–79PubMedCrossRef Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors 2001. JAMA 289:76–79PubMedCrossRef
25.
Zurück zum Zitat Naldi L, Chatenoud L, Belloni A, Peserico A, Balato N, Virgili AR, Bruni PL, Ingordo V, Lo Scocco G, Solaroli C, Schena D, Di Landro A, Pezzarossa E, Arcangeli F, Gianni C, Betti R, Carli P, Farris A, Barabino GF, La Vecchia C, Parazzini F (2008) Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. Dermatology 216:125–130PubMedCrossRef Naldi L, Chatenoud L, Belloni A, Peserico A, Balato N, Virgili AR, Bruni PL, Ingordo V, Lo Scocco G, Solaroli C, Schena D, Di Landro A, Pezzarossa E, Arcangeli F, Gianni C, Betti R, Carli P, Farris A, Barabino GF, La Vecchia C, Parazzini F (2008) Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. Dermatology 216:125–130PubMedCrossRef
26.
Zurück zum Zitat Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55:829–835PubMedCrossRef Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55:829–835PubMedCrossRef
27.
Zurück zum Zitat Ng MC, Miyake K, So WY, Poon EW, Lam VK, Li JK, Cox NJ, Bell GI, Chan JC (2005) The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population. Diabetologia 48:2018–2024PubMedCrossRef Ng MC, Miyake K, So WY, Poon EW, Lam VK, Li JK, Cox NJ, Bell GI, Chan JC (2005) The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population. Diabetologia 48:2018–2024PubMedCrossRef
28.
Zurück zum Zitat Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, Federman DG (2009) Association of psoriasis with coronary artery, cerebrovascular and peripheral vascular diseases and mortality. Arch Dermatol 145:700–703PubMedCrossRef Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, Federman DG (2009) Association of psoriasis with coronary artery, cerebrovascular and peripheral vascular diseases and mortality. Arch Dermatol 145:700–703PubMedCrossRef
29.
Zurück zum Zitat Qureshi AA, Choi HK, Setty AR, Curhan GC (2009) Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 145:379–382PubMedCrossRef Qureshi AA, Choi HK, Setty AR, Curhan GC (2009) Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 145:379–382PubMedCrossRef
30.
Zurück zum Zitat Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM (1999) Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 41:401–407PubMedCrossRef Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM (1999) Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 41:401–407PubMedCrossRef
31.
Zurück zum Zitat Schmitt J, Ford DE (2010) Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol 24:885–892PubMedCrossRef Schmitt J, Ford DE (2010) Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol 24:885–892PubMedCrossRef
32.
Zurück zum Zitat Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A, Kremer E, Heymann A (2007) The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case–control study. J Am Acad Dermatol 56:629–634PubMedCrossRef Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A, Kremer E, Heymann A (2007) The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case–control study. J Am Acad Dermatol 56:629–634PubMedCrossRef
33.
Zurück zum Zitat Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M (2006) Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 298:321–328PubMedCrossRef Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M (2006) Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 298:321–328PubMedCrossRef
34.
Zurück zum Zitat Srinivas M, Narayana P, Surender T, Krishna DR (2008) Study of insulin resistance in relation to serum IGF-I levels in treated type-II diabetic patients. J Assoc Physicians India 56:645–646PubMed Srinivas M, Narayana P, Surender T, Krishna DR (2008) Study of insulin resistance in relation to serum IGF-I levels in treated type-II diabetic patients. J Assoc Physicians India 56:645–646PubMed
35.
Zurück zum Zitat Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, Styrkarsdottir U, Gretarsdottir S, Emilsson V, Ghosh S, Baker A, Snorradottir S, Bjarnason H, Ng MC, Hansen T, Bagger Y, Wilensky RL, Reilly MP, Adeyemo A, Chen Y, Zhou J, Gudnason V, Chen G, Huang H, Lashley K, Doumatey A, So WY, Ma RC, Andersen G, Borch-Johnsen K, Jorgensen T, van Vliet-Ostaptchouk JV, Hofker MH, Wijmenga C, Christiansen C, Rader DJ, Rotimi C, Gurney M, Chan JC, Pedersen O, Sigurdsson G, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39:770–775PubMedCrossRef Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, Styrkarsdottir U, Gretarsdottir S, Emilsson V, Ghosh S, Baker A, Snorradottir S, Bjarnason H, Ng MC, Hansen T, Bagger Y, Wilensky RL, Reilly MP, Adeyemo A, Chen Y, Zhou J, Gudnason V, Chen G, Huang H, Lashley K, Doumatey A, So WY, Ma RC, Andersen G, Borch-Johnsen K, Jorgensen T, van Vliet-Ostaptchouk JV, Hofker MH, Wijmenga C, Christiansen C, Rader DJ, Rotimi C, Gurney M, Chan JC, Pedersen O, Sigurdsson G, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39:770–775PubMedCrossRef
36.
Zurück zum Zitat Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T (2004) Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 9:136–139PubMedCrossRef Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T (2004) Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 9:136–139PubMedCrossRef
37.
Zurück zum Zitat Vena GA, Altomare G, Ayala F, Berardesca E, Calzavara-Pinton P, Chimenti S, Giannetti A, Girolomoni G, Lotti T, Martini P, Mazzaglia G, Peserico A, Puglisi Guerra A, Sini G, Cassano N, Cricelli C (2010) Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol 20:593–598PubMed Vena GA, Altomare G, Ayala F, Berardesca E, Calzavara-Pinton P, Chimenti S, Giannetti A, Girolomoni G, Lotti T, Martini P, Mazzaglia G, Peserico A, Puglisi Guerra A, Sini G, Cassano N, Cricelli C (2010) Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol 20:593–598PubMed
38.
Zurück zum Zitat Wannamethee SG, Shaper AG, Lennon L, Morris RW (2005) Metabolic syndrome vs. Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165:2644–2650PubMedCrossRef Wannamethee SG, Shaper AG, Lennon L, Morris RW (2005) Metabolic syndrome vs. Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165:2644–2650PubMedCrossRef
39.
Zurück zum Zitat Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605PubMedCrossRef Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605PubMedCrossRef
40.
Zurück zum Zitat Wolf N, Quaranta M, Prescott NJ, Allen M, Smith R, Burden AD, Worthington J, Griffiths CE, Mathew CG, Barker JN, Capon F, Trembath RC (2008) Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet 45:114–116PubMedCrossRef Wolf N, Quaranta M, Prescott NJ, Allen M, Smith R, Burden AD, Worthington J, Griffiths CE, Mathew CG, Barker JN, Capon F, Trembath RC (2008) Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet 45:114–116PubMedCrossRef
41.
Zurück zum Zitat Xiao J, Chen LH, Tu YT, Deng XH, Tao J (2009) Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol 23:1311–1315PubMedCrossRef Xiao J, Chen LH, Tu YT, Deng XH, Tao J (2009) Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol 23:1311–1315PubMedCrossRef
42.
Zurück zum Zitat Yoo H, Kim S-J, Kim Y, Lee H, Kim TY (2007) Insulin-like growth factor-II regulates the 12-lipoxygenase gene expression and promotes cell proliferation in human keratinocytes via the extracellular regulatory kinase and phosphatidylinositol 3-kinase pathways. Int J Biochem Cell Biol 39:1248–1259PubMedCrossRef Yoo H, Kim S-J, Kim Y, Lee H, Kim TY (2007) Insulin-like growth factor-II regulates the 12-lipoxygenase gene expression and promotes cell proliferation in human keratinocytes via the extracellular regulatory kinase and phosphatidylinositol 3-kinase pathways. Int J Biochem Cell Biol 39:1248–1259PubMedCrossRef
Metadaten
Titel
Psoriasis increased the risk of diabetes: a meta-analysis
verfasst von
Juan Cheng
Dayu Kuai
Li Zhang
Xueqin Yang
Bing Qiu
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Dermatological Research / Ausgabe 2/2012
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-011-1200-6

Weitere Artikel der Ausgabe 2/2012

Archives of Dermatological Research 2/2012 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.